|
Volumn 38, Issue 7, 2014, Pages 1013-1015
|
Observations on Aron et al's "utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3 CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia"
a a a b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAGNOSTIC AGENT;
MONOCLONAL ANTIBODY;
TUMOR MARKER;
BLADDER TUMOR;
CARCINOMA IN SITU;
HUMAN;
LETTER;
TRANSITIONAL CELL CARCINOMA;
ANTIBODIES, MONOCLONAL;
CARCINOMA IN SITU;
CARCINOMA, TRANSITIONAL CELL;
HUMANS;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
EID: 84902544995
PISSN: 01475185
EISSN: 15320979
Source Type: Journal
DOI: 10.1097/PAS.0000000000000191 Document Type: Letter |
Times cited : (5)
|
References (6)
|